The latest news, stories and exciting findings from across the Oxford cancer research community
New Study Finds Common Virus May Improve Skin Cancer Treatment Outcomes
23 April 2025
A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
New vaccines that aim to prevent cancer: Starting the conversation
14 April 2025
A joint event from the Centre for Personalised Medicine (CPM) & Oxford Centre for Cancer Early Detection and Prevention (OxCODE) on Monday 2nd June 2025.
CRUK funding for research into earlier detection of relapse in people with multiple myeloma
9 April 2025
Dr Karthik Ramasamy and team will assess a new mass spectrometry-based monitoring technique for its ability to predict and identify early disease relapse.
£5.5m Research Funding to Transform Bowel Cancer Care
31 March 2025
Cancer Research UK and partners have today committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. The team will be co-led by Professor Simon Leedham from the Nuffield Department of Medicine at the University of Oxford.
Project submissions welcome for the DPhil in Cancer Science
28 March 2025
The DPhil in Cancer Science is inviting PIs from across Oxford University’s medical, physical, engineering, data, and mathematical sciences to submit their project ideas for its 2026 intake.
Daily physical activity, even at light intensities, linked to lower cancer risk
27 March 2025
A study led by researchers from Oxford Population Health has found that daily physical activity is linked to a lower risk of cancer. The number of steps taken daily may be more important for cancer risk than the intensity of activity.
Showcasing cutting edge-cancer research at the 12th Annual Oxford Cancer Symposium
27 March 2025
The 12th Annual Oxford Cancer Symposium, supported by the CRUK Oxford Centre, took place this year on the 18th March at the University's Mathematical Institute.
Join the Laboratory Efficiency Assessment Framework!
26 March 2025
From 2025, Cancer Research UK (CRUK) will require all new wet-lab grant applications to have sustainability accreditation. Join the Laboratory Efficiency Assessment Framework (LEAF) now for support in meeting these new requirements!
CRUK funding for therapeutic HPV vaccine to prevent HPV-associated cancers
26 March 2025
Dr Karin Hellner is awarded a CRUK Biology to Prevention grant to undertake pre-clinical research into a broad-coverage vaccine to treat chronic human papillomavirus infection.
New biopsy technique found to improve prostate cancer detection
24 March 2025
Researchers from around the UK, led by the University of Oxford, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is more painful for patients.
Research shows importance of genomic testing and targeted therapies for advanced cancers
24 March 2025
Genomic testing and targeted therapies for patients with advanced cancer could improve survival rates by up to 40%, according to researchers at the Norfolk and Norwich University Hospital, University of Adelaide and University of Oxford.
Dr David Church awarded Senior Cancer Research Fellowship from Cancer Research UK
21 March 2025
David’s research will focus on immune dysregulation in colorectal and endometrial pre-cancers and cancers.
Danny Gold - Winner of CRUK's Research is Beautiful campaign
13 March 2025
CRUK's Research is beautiful image campaign highlights images that showcase your research – from your science, to the people in your lab and everything that surrounds it.
Dr Parinaz Mehdipour awarded CRUK Early Detection and Diagnosis Primer Award
5 March 2025
Ludwig Oxford’s Parinaz Mehdipour has been awarded a CRUK Early Detection and Diagnosis Primer to identify circular RNA biomarkers for the early detection of normal colon cell transformation into precancerous and colorectal cancer states
Oxford Cancer Hosts Inaugural Oesophagogastric Cancer Centre of Excellence Symposium
28 February 2025
The inaugural Oxford Oesophagogastric Cancer Centre of Excellence Symposium took place on Tuesday, 25th February, at Lincoln College, Oxford. The event brought together collaborators from across Oxford and further afield who share a commitment to advancing research into and treatment for oesophagogastric cancer.
OCION: In conversation with Tamsin Cargill
28 February 2025
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with OCION Pump Prime awardee - Dr. Tamsin Cargill - to discuss her research.
Lifestyle and environmental factors affect health and ageing more than our genes
19 February 2025
A new study led by researchers from Oxford Population Health has shown that a range of environmental factors have a greater impact on health and premature death than our genes. The researchers used data from nearly half a million UK Biobank participants to assess the influence of 164 environmental factors and genetic risk scores for 22 major diseases (including some cancers) on ageing, age-related diseases, and premature death.
Pancreatic cancer immune map provides clues for precision treatment targeting
6 February 2025
New research - published today in Nature Communications - shows why there are differences in prognosis between different pancreatic tumours and identifies potential avenues for improved treatment approaches.
World Cancer Day 2025: United By Unique
4 February 2025
On World Cancer Day, Dr Sharon Tonner reflects on the theme 'United by Unique', sharing how the team in the Nuffield Department of Primary Care and Health Sciences is navigating and addressing the need for patient-centered care and inclusive, equitable research.
Bowel cancer prediction test for IBD patients 90% accurate
3 February 2025
Researchers in NDM have authored a collaborative study which explored a new method for detecting bowel cancer, which was found to be more than 90% accurate at predicting which higher-risk people will develop this type of cancer in the future.